Global Clinical Next Generation Sequencing (NGS) Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Clinical Next Generation Sequencing (NGS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Clinical Next Generation Sequencing (NGS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Clinical Next Generation Sequencing (NGS) market in any manner.
Global Clinical Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI Group
Qiagen
Roche Diagnostics
Bio-Rad
Congenica
Theragen Etex
PerkinElmer
Partek
Oxford Nanopore Technologies
Pacific Biosciences of California
Golden Helix
BioDatomics
PierianDx
DNAStar
Market Segmentation (by Type)
Sequencing by Synthesis (SBS)
Nanopore Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Others
Market Segmentation (by Application)
Diagnostics
Drug Discovery & Designing
Medical Research
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Clinical Next Generation Sequencing (NGS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Clinical Next Generation Sequencing (NGS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Clinical Next Generation Sequencing (NGS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Clinical Next Generation Sequencing (NGS) market in any manner.
Global Clinical Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI Group
Qiagen
Roche Diagnostics
Bio-Rad
Congenica
Theragen Etex
PerkinElmer
Partek
Oxford Nanopore Technologies
Pacific Biosciences of California
Golden Helix
BioDatomics
PierianDx
DNAStar
Market Segmentation (by Type)
Sequencing by Synthesis (SBS)
Nanopore Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Others
Market Segmentation (by Application)
Diagnostics
Drug Discovery & Designing
Medical Research
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Clinical Next Generation Sequencing (NGS) Market
- Overview of the regional outlook of the Clinical Next Generation Sequencing (NGS) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Clinical Next Generation Sequencing (NGS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Clinical Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Clinical Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Clinical Next Generation Sequencing (NGS) Sales by Manufacturers (2019-2024)
3.2 Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2019-2024)
3.3 Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Clinical Next Generation Sequencing (NGS) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Clinical Next Generation Sequencing (NGS) Sales Sites, Area Served, Product Type
3.6 Clinical Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.6.1 Clinical Next Generation Sequencing (NGS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Clinical Next Generation Sequencing (NGS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CLINICAL NEXT GENERATION SEQUENCING (NGS) INDUSTRY CHAIN ANALYSIS
4.1 Clinical Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
6.3 Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
6.4 Global Clinical Next Generation Sequencing (NGS) Price by Type (2019-2024)
7 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Next Generation Sequencing (NGS) Market Sales by Application (2019-2024)
7.3 Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) by Application (2019-2024)
7.4 Global Clinical Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
8 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY REGION
8.1 Global Clinical Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 North America
8.2.1 North America Clinical Next Generation Sequencing (NGS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Clinical Next Generation Sequencing (NGS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Clinical Next Generation Sequencing (NGS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Clinical Next Generation Sequencing (NGS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies Clinical Next Generation Sequencing (NGS) Basic Information
9.1.2 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Overview
9.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies Clinical Next Generation Sequencing (NGS) SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 Illumina
9.2.1 Illumina Clinical Next Generation Sequencing (NGS) Basic Information
9.2.2 Illumina Clinical Next Generation Sequencing (NGS) Product Overview
9.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product Market Performance
9.2.4 Illumina Business Overview
9.2.5 Illumina Clinical Next Generation Sequencing (NGS) SWOT Analysis
9.2.6 Illumina Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Basic Information
9.3.2 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Overview
9.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Market Performance
9.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Basic Information
9.4.2 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Overview
9.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Market Performance
9.4.4 Eurofins Scientific Business Overview
9.4.5 Eurofins Scientific Recent Developments
9.5 BGI Group
9.5.1 BGI Group Clinical Next Generation Sequencing (NGS) Basic Information
9.5.2 BGI Group Clinical Next Generation Sequencing (NGS) Product Overview
9.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product Market Performance
9.5.4 BGI Group Business Overview
9.5.5 BGI Group Recent Developments
9.6 Qiagen
9.6.1 Qiagen Clinical Next Generation Sequencing (NGS) Basic Information
9.6.2 Qiagen Clinical Next Generation Sequencing (NGS) Product Overview
9.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 Roche Diagnostics
9.7.1 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Basic Information
9.7.2 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Overview
9.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Market Performance
9.7.4 Roche Diagnostics Business Overview
9.7.5 Roche Diagnostics Recent Developments
9.8 Bio-Rad
9.8.1 Bio-Rad Clinical Next Generation Sequencing (NGS) Basic Information
9.8.2 Bio-Rad Clinical Next Generation Sequencing (NGS) Product Overview
9.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product Market Performance
9.8.4 Bio-Rad Business Overview
9.8.5 Bio-Rad Recent Developments
9.9 Congenica
9.9.1 Congenica Clinical Next Generation Sequencing (NGS) Basic Information
9.9.2 Congenica Clinical Next Generation Sequencing (NGS) Product Overview
9.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product Market Performance
9.9.4 Congenica Business Overview
9.9.5 Congenica Recent Developments
9.10 Theragen Etex
9.10.1 Theragen Etex Clinical Next Generation Sequencing (NGS) Basic Information
9.10.2 Theragen Etex Clinical Next Generation Sequencing (NGS) Product Overview
9.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product Market Performance
9.10.4 Theragen Etex Business Overview
9.10.5 Theragen Etex Recent Developments
9.11 PerkinElmer
9.11.1 PerkinElmer Clinical Next Generation Sequencing (NGS) Basic Information
9.11.2 PerkinElmer Clinical Next Generation Sequencing (NGS) Product Overview
9.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product Market Performance
9.11.4 PerkinElmer Business Overview
9.11.5 PerkinElmer Recent Developments
9.12 Partek
9.12.1 Partek Clinical Next Generation Sequencing (NGS) Basic Information
9.12.2 Partek Clinical Next Generation Sequencing (NGS) Product Overview
9.12.3 Partek Clinical Next Generation Sequencing (NGS) Product Market Performance
9.12.4 Partek Business Overview
9.12.5 Partek Recent Developments
9.13 Oxford Nanopore Technologies
9.13.1 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Basic Information
9.13.2 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Overview
9.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Market Performance
9.13.4 Oxford Nanopore Technologies Business Overview
9.13.5 Oxford Nanopore Technologies Recent Developments
9.14 Pacific Biosciences of California
9.14.1 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Basic Information
9.14.2 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Overview
9.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Market Performance
9.14.4 Pacific Biosciences of California Business Overview
9.14.5 Pacific Biosciences of California Recent Developments
9.15 Golden Helix
9.15.1 Golden Helix Clinical Next Generation Sequencing (NGS) Basic Information
9.15.2 Golden Helix Clinical Next Generation Sequencing (NGS) Product Overview
9.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product Market Performance
9.15.4 Golden Helix Business Overview
9.15.5 Golden Helix Recent Developments
9.16 BioDatomics
9.16.1 BioDatomics Clinical Next Generation Sequencing (NGS) Basic Information
9.16.2 BioDatomics Clinical Next Generation Sequencing (NGS) Product Overview
9.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product Market Performance
9.16.4 BioDatomics Business Overview
9.16.5 BioDatomics Recent Developments
9.17 PierianDx
9.17.1 PierianDx Clinical Next Generation Sequencing (NGS) Basic Information
9.17.2 PierianDx Clinical Next Generation Sequencing (NGS) Product Overview
9.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product Market Performance
9.17.4 PierianDx Business Overview
9.17.5 PierianDx Recent Developments
9.18 DNAStar
9.18.1 DNAStar Clinical Next Generation Sequencing (NGS) Basic Information
9.18.2 DNAStar Clinical Next Generation Sequencing (NGS) Product Overview
9.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product Market Performance
9.18.4 DNAStar Business Overview
9.18.5 DNAStar Recent Developments
10 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST BY REGION
10.1 Global Clinical Next Generation Sequencing (NGS) Market Size Forecast
10.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.3 Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size Forecast by Region
10.2.4 South America Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Clinical Next Generation Sequencing (NGS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Clinical Next Generation Sequencing (NGS) by Type (2025-2030)
11.1.2 Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Clinical Next Generation Sequencing (NGS) by Type (2025-2030)
11.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Application (2025-2030)
11.2.1 Global Clinical Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
11.2.2 Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Clinical Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Clinical Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Clinical Next Generation Sequencing (NGS) Sales by Manufacturers (2019-2024)
3.2 Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2019-2024)
3.3 Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Clinical Next Generation Sequencing (NGS) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Clinical Next Generation Sequencing (NGS) Sales Sites, Area Served, Product Type
3.6 Clinical Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.6.1 Clinical Next Generation Sequencing (NGS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Clinical Next Generation Sequencing (NGS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CLINICAL NEXT GENERATION SEQUENCING (NGS) INDUSTRY CHAIN ANALYSIS
4.1 Clinical Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
6.3 Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
6.4 Global Clinical Next Generation Sequencing (NGS) Price by Type (2019-2024)
7 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Next Generation Sequencing (NGS) Market Sales by Application (2019-2024)
7.3 Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) by Application (2019-2024)
7.4 Global Clinical Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
8 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY REGION
8.1 Global Clinical Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 North America
8.2.1 North America Clinical Next Generation Sequencing (NGS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Clinical Next Generation Sequencing (NGS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Clinical Next Generation Sequencing (NGS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Clinical Next Generation Sequencing (NGS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies Clinical Next Generation Sequencing (NGS) Basic Information
9.1.2 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Overview
9.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies Clinical Next Generation Sequencing (NGS) SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 Illumina
9.2.1 Illumina Clinical Next Generation Sequencing (NGS) Basic Information
9.2.2 Illumina Clinical Next Generation Sequencing (NGS) Product Overview
9.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product Market Performance
9.2.4 Illumina Business Overview
9.2.5 Illumina Clinical Next Generation Sequencing (NGS) SWOT Analysis
9.2.6 Illumina Recent Developments
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Basic Information
9.3.2 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Overview
9.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Market Performance
9.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) SWOT Analysis
9.3.5 Thermo Fisher Scientific Business Overview
9.3.6 Thermo Fisher Scientific Recent Developments
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Basic Information
9.4.2 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Overview
9.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Market Performance
9.4.4 Eurofins Scientific Business Overview
9.4.5 Eurofins Scientific Recent Developments
9.5 BGI Group
9.5.1 BGI Group Clinical Next Generation Sequencing (NGS) Basic Information
9.5.2 BGI Group Clinical Next Generation Sequencing (NGS) Product Overview
9.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product Market Performance
9.5.4 BGI Group Business Overview
9.5.5 BGI Group Recent Developments
9.6 Qiagen
9.6.1 Qiagen Clinical Next Generation Sequencing (NGS) Basic Information
9.6.2 Qiagen Clinical Next Generation Sequencing (NGS) Product Overview
9.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 Roche Diagnostics
9.7.1 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Basic Information
9.7.2 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Overview
9.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Market Performance
9.7.4 Roche Diagnostics Business Overview
9.7.5 Roche Diagnostics Recent Developments
9.8 Bio-Rad
9.8.1 Bio-Rad Clinical Next Generation Sequencing (NGS) Basic Information
9.8.2 Bio-Rad Clinical Next Generation Sequencing (NGS) Product Overview
9.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product Market Performance
9.8.4 Bio-Rad Business Overview
9.8.5 Bio-Rad Recent Developments
9.9 Congenica
9.9.1 Congenica Clinical Next Generation Sequencing (NGS) Basic Information
9.9.2 Congenica Clinical Next Generation Sequencing (NGS) Product Overview
9.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product Market Performance
9.9.4 Congenica Business Overview
9.9.5 Congenica Recent Developments
9.10 Theragen Etex
9.10.1 Theragen Etex Clinical Next Generation Sequencing (NGS) Basic Information
9.10.2 Theragen Etex Clinical Next Generation Sequencing (NGS) Product Overview
9.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product Market Performance
9.10.4 Theragen Etex Business Overview
9.10.5 Theragen Etex Recent Developments
9.11 PerkinElmer
9.11.1 PerkinElmer Clinical Next Generation Sequencing (NGS) Basic Information
9.11.2 PerkinElmer Clinical Next Generation Sequencing (NGS) Product Overview
9.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product Market Performance
9.11.4 PerkinElmer Business Overview
9.11.5 PerkinElmer Recent Developments
9.12 Partek
9.12.1 Partek Clinical Next Generation Sequencing (NGS) Basic Information
9.12.2 Partek Clinical Next Generation Sequencing (NGS) Product Overview
9.12.3 Partek Clinical Next Generation Sequencing (NGS) Product Market Performance
9.12.4 Partek Business Overview
9.12.5 Partek Recent Developments
9.13 Oxford Nanopore Technologies
9.13.1 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Basic Information
9.13.2 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Overview
9.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Market Performance
9.13.4 Oxford Nanopore Technologies Business Overview
9.13.5 Oxford Nanopore Technologies Recent Developments
9.14 Pacific Biosciences of California
9.14.1 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Basic Information
9.14.2 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Overview
9.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Market Performance
9.14.4 Pacific Biosciences of California Business Overview
9.14.5 Pacific Biosciences of California Recent Developments
9.15 Golden Helix
9.15.1 Golden Helix Clinical Next Generation Sequencing (NGS) Basic Information
9.15.2 Golden Helix Clinical Next Generation Sequencing (NGS) Product Overview
9.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product Market Performance
9.15.4 Golden Helix Business Overview
9.15.5 Golden Helix Recent Developments
9.16 BioDatomics
9.16.1 BioDatomics Clinical Next Generation Sequencing (NGS) Basic Information
9.16.2 BioDatomics Clinical Next Generation Sequencing (NGS) Product Overview
9.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product Market Performance
9.16.4 BioDatomics Business Overview
9.16.5 BioDatomics Recent Developments
9.17 PierianDx
9.17.1 PierianDx Clinical Next Generation Sequencing (NGS) Basic Information
9.17.2 PierianDx Clinical Next Generation Sequencing (NGS) Product Overview
9.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product Market Performance
9.17.4 PierianDx Business Overview
9.17.5 PierianDx Recent Developments
9.18 DNAStar
9.18.1 DNAStar Clinical Next Generation Sequencing (NGS) Basic Information
9.18.2 DNAStar Clinical Next Generation Sequencing (NGS) Product Overview
9.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product Market Performance
9.18.4 DNAStar Business Overview
9.18.5 DNAStar Recent Developments
10 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST BY REGION
10.1 Global Clinical Next Generation Sequencing (NGS) Market Size Forecast
10.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.3 Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size Forecast by Region
10.2.4 South America Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Clinical Next Generation Sequencing (NGS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Clinical Next Generation Sequencing (NGS) by Type (2025-2030)
11.1.2 Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Clinical Next Generation Sequencing (NGS) by Type (2025-2030)
11.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Application (2025-2030)
11.2.1 Global Clinical Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
11.2.2 Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Clinical Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 5. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Clinical Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next Generation Sequencing (NGS) as of 2022)
Table 10. Global Market Clinical Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Clinical Next Generation Sequencing (NGS) Sales Sites and Area Served
Table 12. Manufacturers Clinical Next Generation Sequencing (NGS) Product Type
Table 13. Global Clinical Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Clinical Next Generation Sequencing (NGS)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Next Generation Sequencing (NGS) Market Challenges
Table 22. Global Clinical Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 23. Global Clinical Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 24. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) by Type (2019-2024)
Table 25. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
Table 26. Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) by Type (2019-2024)
Table 27. Global Clinical Next Generation Sequencing (NGS) Market Size Share by Type (2019-2024)
Table 28. Global Clinical Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 30. Global Clinical Next Generation Sequencing (NGS) Market Size by Application
Table 31. Global Clinical Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (K Units)
Table 32. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Table 33. Global Clinical Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (M USD)
Table 34. Global Clinical Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Table 35. Global Clinical Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Table 36. Global Clinical Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 37. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Table 38. North America Clinical Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Clinical Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 41. South America Clinical Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies Clinical Next Generation Sequencing (NGS) Basic Information
Table 44. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Overview
Table 45. Agilent Technologies Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Clinical Next Generation Sequencing (NGS) SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. Illumina Clinical Next Generation Sequencing (NGS) Basic Information
Table 50. Illumina Clinical Next Generation Sequencing (NGS) Product Overview
Table 51. Illumina Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Illumina Business Overview
Table 53. Illumina Clinical Next Generation Sequencing (NGS) SWOT Analysis
Table 54. Illumina Recent Developments
Table 55. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Basic Information
Table 56. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Overview
Table 57. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Basic Information
Table 62. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Overview
Table 63. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Recent Developments
Table 66. BGI Group Clinical Next Generation Sequencing (NGS) Basic Information
Table 67. BGI Group Clinical Next Generation Sequencing (NGS) Product Overview
Table 68. BGI Group Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BGI Group Business Overview
Table 70. BGI Group Recent Developments
Table 71. Qiagen Clinical Next Generation Sequencing (NGS) Basic Information
Table 72. Qiagen Clinical Next Generation Sequencing (NGS) Product Overview
Table 73. Qiagen Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Qiagen Business Overview
Table 75. Qiagen Recent Developments
Table 76. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Basic Information
Table 77. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Overview
Table 78. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Roche Diagnostics Business Overview
Table 80. Roche Diagnostics Recent Developments
Table 81. Bio-Rad Clinical Next Generation Sequencing (NGS) Basic Information
Table 82. Bio-Rad Clinical Next Generation Sequencing (NGS) Product Overview
Table 83. Bio-Rad Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bio-Rad Business Overview
Table 85. Bio-Rad Recent Developments
Table 86. Congenica Clinical Next Generation Sequencing (NGS) Basic Information
Table 87. Congenica Clinical Next Generation Sequencing (NGS) Product Overview
Table 88. Congenica Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Congenica Business Overview
Table 90. Congenica Recent Developments
Table 91. Theragen Etex Clinical Next Generation Sequencing (NGS) Basic Information
Table 92. Theragen Etex Clinical Next Generation Sequencing (NGS) Product Overview
Table 93. Theragen Etex Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Theragen Etex Business Overview
Table 95. Theragen Etex Recent Developments
Table 96. PerkinElmer Clinical Next Generation Sequencing (NGS) Basic Information
Table 97. PerkinElmer Clinical Next Generation Sequencing (NGS) Product Overview
Table 98. PerkinElmer Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. PerkinElmer Business Overview
Table 100. PerkinElmer Recent Developments
Table 101. Partek Clinical Next Generation Sequencing (NGS) Basic Information
Table 102. Partek Clinical Next Generation Sequencing (NGS) Product Overview
Table 103. Partek Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Partek Business Overview
Table 105. Partek Recent Developments
Table 106. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Basic Information
Table 107. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Overview
Table 108. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Oxford Nanopore Technologies Business Overview
Table 110. Oxford Nanopore Technologies Recent Developments
Table 111. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Basic Information
Table 112. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Overview
Table 113. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Pacific Biosciences of California Business Overview
Table 115. Pacific Biosciences of California Recent Developments
Table 116. Golden Helix Clinical Next Generation Sequencing (NGS) Basic Information
Table 117. Golden Helix Clinical Next Generation Sequencing (NGS) Product Overview
Table 118. Golden Helix Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Golden Helix Business Overview
Table 120. Golden Helix Recent Developments
Table 121. BioDatomics Clinical Next Generation Sequencing (NGS) Basic Information
Table 122. BioDatomics Clinical Next Generation Sequencing (NGS) Product Overview
Table 123. BioDatomics Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. BioDatomics Business Overview
Table 125. BioDatomics Recent Developments
Table 126. PierianDx Clinical Next Generation Sequencing (NGS) Basic Information
Table 127. PierianDx Clinical Next Generation Sequencing (NGS) Product Overview
Table 128. PierianDx Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. PierianDx Business Overview
Table 130. PierianDx Recent Developments
Table 131. DNAStar Clinical Next Generation Sequencing (NGS) Basic Information
Table 132. DNAStar Clinical Next Generation Sequencing (NGS) Product Overview
Table 133. DNAStar Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. DNAStar Business Overview
Table 135. DNAStar Recent Developments
Table 136. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Clinical Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Clinical Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Clinical Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Clinical Next Generation Sequencing (NGS) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Clinical Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 5. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Clinical Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next Generation Sequencing (NGS) as of 2022)
Table 10. Global Market Clinical Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Clinical Next Generation Sequencing (NGS) Sales Sites and Area Served
Table 12. Manufacturers Clinical Next Generation Sequencing (NGS) Product Type
Table 13. Global Clinical Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Clinical Next Generation Sequencing (NGS)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Next Generation Sequencing (NGS) Market Challenges
Table 22. Global Clinical Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 23. Global Clinical Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 24. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) by Type (2019-2024)
Table 25. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
Table 26. Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) by Type (2019-2024)
Table 27. Global Clinical Next Generation Sequencing (NGS) Market Size Share by Type (2019-2024)
Table 28. Global Clinical Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 30. Global Clinical Next Generation Sequencing (NGS) Market Size by Application
Table 31. Global Clinical Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (K Units)
Table 32. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Table 33. Global Clinical Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (M USD)
Table 34. Global Clinical Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Table 35. Global Clinical Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Table 36. Global Clinical Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 37. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Table 38. North America Clinical Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Clinical Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 41. South America Clinical Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies Clinical Next Generation Sequencing (NGS) Basic Information
Table 44. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Overview
Table 45. Agilent Technologies Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies Clinical Next Generation Sequencing (NGS) SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. Illumina Clinical Next Generation Sequencing (NGS) Basic Information
Table 50. Illumina Clinical Next Generation Sequencing (NGS) Product Overview
Table 51. Illumina Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Illumina Business Overview
Table 53. Illumina Clinical Next Generation Sequencing (NGS) SWOT Analysis
Table 54. Illumina Recent Developments
Table 55. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Basic Information
Table 56. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Overview
Table 57. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Basic Information
Table 62. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Overview
Table 63. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Recent Developments
Table 66. BGI Group Clinical Next Generation Sequencing (NGS) Basic Information
Table 67. BGI Group Clinical Next Generation Sequencing (NGS) Product Overview
Table 68. BGI Group Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BGI Group Business Overview
Table 70. BGI Group Recent Developments
Table 71. Qiagen Clinical Next Generation Sequencing (NGS) Basic Information
Table 72. Qiagen Clinical Next Generation Sequencing (NGS) Product Overview
Table 73. Qiagen Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Qiagen Business Overview
Table 75. Qiagen Recent Developments
Table 76. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Basic Information
Table 77. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Overview
Table 78. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Roche Diagnostics Business Overview
Table 80. Roche Diagnostics Recent Developments
Table 81. Bio-Rad Clinical Next Generation Sequencing (NGS) Basic Information
Table 82. Bio-Rad Clinical Next Generation Sequencing (NGS) Product Overview
Table 83. Bio-Rad Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bio-Rad Business Overview
Table 85. Bio-Rad Recent Developments
Table 86. Congenica Clinical Next Generation Sequencing (NGS) Basic Information
Table 87. Congenica Clinical Next Generation Sequencing (NGS) Product Overview
Table 88. Congenica Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Congenica Business Overview
Table 90. Congenica Recent Developments
Table 91. Theragen Etex Clinical Next Generation Sequencing (NGS) Basic Information
Table 92. Theragen Etex Clinical Next Generation Sequencing (NGS) Product Overview
Table 93. Theragen Etex Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Theragen Etex Business Overview
Table 95. Theragen Etex Recent Developments
Table 96. PerkinElmer Clinical Next Generation Sequencing (NGS) Basic Information
Table 97. PerkinElmer Clinical Next Generation Sequencing (NGS) Product Overview
Table 98. PerkinElmer Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. PerkinElmer Business Overview
Table 100. PerkinElmer Recent Developments
Table 101. Partek Clinical Next Generation Sequencing (NGS) Basic Information
Table 102. Partek Clinical Next Generation Sequencing (NGS) Product Overview
Table 103. Partek Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Partek Business Overview
Table 105. Partek Recent Developments
Table 106. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Basic Information
Table 107. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Overview
Table 108. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Oxford Nanopore Technologies Business Overview
Table 110. Oxford Nanopore Technologies Recent Developments
Table 111. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Basic Information
Table 112. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Overview
Table 113. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Pacific Biosciences of California Business Overview
Table 115. Pacific Biosciences of California Recent Developments
Table 116. Golden Helix Clinical Next Generation Sequencing (NGS) Basic Information
Table 117. Golden Helix Clinical Next Generation Sequencing (NGS) Product Overview
Table 118. Golden Helix Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Golden Helix Business Overview
Table 120. Golden Helix Recent Developments
Table 121. BioDatomics Clinical Next Generation Sequencing (NGS) Basic Information
Table 122. BioDatomics Clinical Next Generation Sequencing (NGS) Product Overview
Table 123. BioDatomics Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. BioDatomics Business Overview
Table 125. BioDatomics Recent Developments
Table 126. PierianDx Clinical Next Generation Sequencing (NGS) Basic Information
Table 127. PierianDx Clinical Next Generation Sequencing (NGS) Product Overview
Table 128. PierianDx Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. PierianDx Business Overview
Table 130. PierianDx Recent Developments
Table 131. DNAStar Clinical Next Generation Sequencing (NGS) Basic Information
Table 132. DNAStar Clinical Next Generation Sequencing (NGS) Product Overview
Table 133. DNAStar Clinical Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. DNAStar Business Overview
Table 135. DNAStar Recent Developments
Table 136. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Clinical Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Clinical Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Clinical Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Clinical Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Clinical Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Clinical Next Generation Sequencing (NGS) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Clinical Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Next Generation Sequencing (NGS) Market Size (M USD), 2019-2030
Figure 5. Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) (2019-2030)
Figure 6. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Clinical Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2023
Figure 12. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2023
Figure 13. Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Clinical Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Clinical Next Generation Sequencing (NGS) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Clinical Next Generation Sequencing (NGS) Market Share by Type
Figure 18. Sales Market Share of Clinical Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 19. Sales Market Share of Clinical Next Generation Sequencing (NGS) by Type in 2023
Figure 20. Market Size Share of Clinical Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 21. Market Size Market Share of Clinical Next Generation Sequencing (NGS) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Clinical Next Generation Sequencing (NGS) Market Share by Application
Figure 24. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Figure 25. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Application in 2023
Figure 26. Global Clinical Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Figure 27. Global Clinical Next Generation Sequencing (NGS) Market Share by Application in 2023
Figure 28. Global Clinical Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Figure 30. North America Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Clinical Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 32. U.S. Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Clinical Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Clinical Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Clinical Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 37. Germany Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 44. China Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 50. South America Clinical Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 51. Brazil Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Clinical Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Type (2025-2030)
Figure 65. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Application (2025-2030)
Figure 66. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Clinical Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Next Generation Sequencing (NGS) Market Size (M USD), 2019-2030
Figure 5. Global Clinical Next Generation Sequencing (NGS) Market Size (M USD) (2019-2030)
Figure 6. Global Clinical Next Generation Sequencing (NGS) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Clinical Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2023
Figure 12. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2023
Figure 13. Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Clinical Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Clinical Next Generation Sequencing (NGS) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Clinical Next Generation Sequencing (NGS) Market Share by Type
Figure 18. Sales Market Share of Clinical Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 19. Sales Market Share of Clinical Next Generation Sequencing (NGS) by Type in 2023
Figure 20. Market Size Share of Clinical Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 21. Market Size Market Share of Clinical Next Generation Sequencing (NGS) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Clinical Next Generation Sequencing (NGS) Market Share by Application
Figure 24. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Figure 25. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Application in 2023
Figure 26. Global Clinical Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Figure 27. Global Clinical Next Generation Sequencing (NGS) Market Share by Application in 2023
Figure 28. Global Clinical Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Clinical Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Figure 30. North America Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Clinical Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 32. U.S. Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Clinical Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Clinical Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Clinical Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 37. Germany Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 44. China Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 50. South America Clinical Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 51. Brazil Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Clinical Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Clinical Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Clinical Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Type (2025-2030)
Figure 65. Global Clinical Next Generation Sequencing (NGS) Sales Forecast by Application (2025-2030)
Figure 66. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Application (2025-2030)
